Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced-stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high-risk patients from the ECHELON-1 study
Brentuximab vedotin联合多柔比星、长春碱和达卡巴嗪治疗晚期经典型霍奇金淋巴瘤患者：ECHELON-1研究中高危患者的预设亚组分析
期刊:Hematological Oncology
影响因子:3.9
doi:10.1002/hon.2838
Hutchings, Martin; Radford, John; Ansell, Stephen M; Illés, Árpád; Sureda, Anna; Connors, Joseph M; Sýkorová, Alice; Shibayama, Hirohiko; Abramson, Jeremy S; Chua, Neil S; Friedberg, Jonathan W; Kořen, Jan; LaCasce, Ann Steward; Molina, Lysiane; Engley, Gerald; Fenton, Keenan; Jolin, Hina; Liu, Rachael; Gautam, Ashish; Gallamini, Andrea
